The Role of CD133 Expression of Cancer Stem Cells on Radiotherapy Response in Early Stage Glottic Cancers

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2020 Jun 11

PMID 32519080

Authors

Emrah Gulmez

Imdat Yuce

Mete Gundog

Ozlem Canoz

Kerem Kokoglu

Alperen Vural

Sedat Cagli

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the relationship between CD133 positivity and radiotherapy (RT) response in early stage glottic laryngeal cancers.

Methods: Thirty seven patients with early-stage glottic laryngeal carcinoma who were treated with primary RT were evaluated. Patients with regular follow-up of at least 3 years were included in the study. Patients who had previously received chemotherapy for laryngeal surgery or underwent surgery were excluded. The patients were divided into two groups as recurrent and non-recurrent. These two groups were compared in terms of CD133 expression by immunohistochemical method.

Results: There were 37 patients in the study. Ten patients had recurrence and seven (70%) had CD133 positive and three had CD133 negative. Of 27 patients who had no recurrence, 16 (59%) had CD133 positive and 11 (41%) had CD133 negative. 7 (70%) of ten patients with recurrence were found to be positive for CD133; There was no statistically significant difference between recurrent and non-recurrent patient groups in terms of CD133 positivity (p > 0.05). There was no correlation between the final CD133 score and recurrence status as well (p > 0.05).

Conclusion: There was no relationship between radiotherapy response and CD133 staining in early-stage glottic laryngeal cancers. It is the largest study about CD133 and RT sensitivity in early stage glottic carcinomas.

References

Cho R, Clarke M . Recent advances in cancer stem cells. Curr Opin Genet Dev. 2008; 18(1):48-53. DOI: 10.1016/j.gde.2008.01.017. View

Prince M, Sivanandan R, Kaczorowski A, Wolf G, Kaplan M, Dalerba P . Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007; 104(3):973-8. PMC: 1783424. DOI: 10.1073/pnas.0610117104. View

Corbeil D, Roper K, Fargeas C, Joester A, Huttner W . Prominin: a story of cholesterol, plasma membrane protrusions and human pathology. Traffic. 2001; 2(2):82-91. DOI: 10.1034/j.1600-0854.2001.020202.x. View

Mimeault M, Hauke R, Mehta P, Batra S . Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med. 2007; 11(5):981-1011. PMC: 4401269. DOI: 10.1111/j.1582-4934.2007.00088.x. View

Yu L, Zhou L, Wu S, Gong X, Feng Z, Ma L . Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma. World J Surg Oncol. 2014; 12:118. PMC: 4012248. DOI: 10.1186/1477-7819-12-118. View

Almadori G, Bussu F, Cadoni G, Galli J, Paludetti G, Maurizi M . Molecular markers in laryngeal squamous cell carcinoma: towards an integrated clinicobiological approach. Eur J Cancer. 2005; 41(5):683-93. DOI: 10.1016/j.ejca.2004.10.031. View

Tomasino R, Bazan V, Daniele E, Nuara R, Morello V, Tralongo V . Biological characterization of laryngeal squamous-cell carcinoma. Anticancer Res. 1996; 16(4B):2257-67. View

Nix P, Lind M, Greenman J, Stafford N, Cawkwell L . Expression of Cox-2 protein in radioresistant laryngeal cancer. Ann Oncol. 2004; 15(5):797-801. DOI: 10.1093/annonc/mdh185. View

Nix P, Cawkwell L, Patmore H, Greenman J, Stafford N . Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. Br J Cancer. 2005; 92(12):2185-9. PMC: 2361818. DOI: 10.1038/sj.bjc.6602647. View

10.

Fan Z, Li M, Chen X, Wang J, Liang X, Wang H . Prognostic Value of Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma: a Meta-analysis. Sci Rep. 2017; 7:43008. PMC: 5318950. DOI: 10.1038/srep43008. View

11.

Curtarelli R, Goncalves J, Dos Santos L, Savi M, Nor J, Mezzomo L . Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review. Stem Cell Rev Rep. 2018; 14(6):769-784. DOI: 10.1007/s12015-018-9839-4. View

12.

Weigmann A, Corbeil D, Hellwig A, Huttner W . Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A. 1997; 94(23):12425-30. PMC: 24979. DOI: 10.1073/pnas.94.23.12425. View

13.

Szafarowski T, Sierdzinski J, Ludwig N, Gluszko A, Filipowska A, Szczepanski M . Assessment of cancer stem cell marker expression in primary head and neck squamous cell carcinoma shows prognostic value for aldehyde dehydrogenase (ALDH1A1). Eur J Pharmacol. 2019; 867:172837. DOI: 10.1016/j.ejphar.2019.172837. View

14.

Wei X, Wang J, He J, Ma B, Chen J . Biological characteristics of CD133(+) cancer stem cells derived from human laryngeal carcinoma cell line. Int J Clin Exp Med. 2014; 7(9):2453-62. PMC: 4211747. View

15.

Wang J, Wu Y, Gao W, Li F, Bo Y, Zhu M . Identification and characterization of CD133CD44 cancer stem cells from human laryngeal squamous cell carcinoma cell lines. J Cancer. 2017; 8(3):497-506. PMC: 5332902. DOI: 10.7150/jca.17444. View